Why is Torrent Pharma falling/rising?

As of 01-Aug, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at Rs 3,666.25, which reflects a decrease of Rs 94.95 or 2.52%. Despite this drop, the stock has shown positive performance over the past week and month, with returns of 1.61% and 7.41% respectively. Today's trading saw the stock touch an intraday low of Rs 3,643.8, and it is currently 3.38% away from its 52-week high of Rs 3,790. The stock has outperformed its sector by 0.64%, and it is trading above all key moving averages. However, there has been a significant decline in investor participation, with delivery volume falling by 56.18% compared to the 5-day average, which may indicate reduced interest among investors.
In the broader market context, while Torrent Pharmaceuticals has outperformed the Sensex over various periods, including a year-to-date return of 9.26% compared to the Sensex's 3.15%, the pharmaceutical sector overall has seen a decline of 3.26%. The company's strong fundamentals, such as high management efficiency and consistent returns, support its valuation, but concerns about long-term growth and high valuation metrics may be contributing to the current price drop. The stock's performance remains robust relative to its peers, but the recent decrease in trading volume and sector-wide declines could be influencing investor sentiment negatively.